StockNews.com upgraded shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a strong-buy rating in a research note published on Monday morning. Other equities research analysts also recently issued reports about the company. Wells Fargo & Company increased their price target on Elevance Health from $557.00 to $600.00 and gave the […]
EverSource Wealth Advisors LLC increased its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 6.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,124 shares of the company’s stock after purchasing an additional 68 shares during the quarter. EverSource […]
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 12-month price […]
BI Asset Management Fondsmaeglerselskab A S decreased its stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 6.4% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 69,234 shares of the company’s stock after selling 4,743 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Elevance Health were […]
Newport Trust Company LLC cut its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 2.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,210,519 shares of the company’s stock after selling 31,119 shares during the period. Elevance Health […]